Insider · CIK 0001211839

MERRIWEATHER ALFRED G

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001211839

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-09-20	Adamas Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−1,584 sh	$6.91	−$10.9K	48,019
2019-04-08	Adamas Pharmaceuticals IncA Award	Chief Financial Officer	AAward	+25K sh	—	—	49,603
2019-04-08	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2019-03-20	Adamas Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−857 sh	$7.99	−$6,847.43	24,603
2018-09-21	Adamas Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−1,665 sh	$19.18	−$31.9K	25,460
2018-03-06	Adamas Pharmaceuticals IncA Award	Chief Financial Officer	AAward	+8,375 sh	—	—	27,125
2018-03-06	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50.3K sh	—	—	50,250
2017-07-10	Adamas Pharmaceuticals IncA Award	Chief Financial Officer	AAward	+18.8K sh	—	—	18,750
2017-07-10	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+113K sh	—	—	112,500
2011-05-17	Celera CORPStock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−50K sh	$1.66	−$83.1K	0
2011-05-10	Celera CORPU Disposition from Tender	SVP, Chief Financial Officer	UDisposition from Tender	−15.8K sh	$8.00	−$127K	0
2011-05-03	Celera CORPF Tax Payment	SVP, Chief Financial Officer	FTax Payment	−9,172 sh	$8.00	−$73.4K	15,828
2011-01-03	Celera CORPA Award	SVP, Chief Financial Officer	AAward	+25K sh	—	—	25,000
2011-01-03	Celera CORPStock Option (Right to Buy)A Award	SVP, Chief Financial Officer	AAward	+50K sh	—	—	50,000
2009-01-16	Monogram Biosciences, Inc.Stock Option (Rt to Buy)A Award	Sr. VP, CFO	AAward	+35K sh	—	—	35,000
2009-01-16	Monogram Biosciences, Inc.Stock Option (Rt to Buy)A Award	Sr. VP, CFO	AAward	+35K sh	—	—	35,000
2004-02-06	ACLARA BIOSCIENCES INCEmployee Stock Option (right to buy)A Award	VP Finance, CFO	AAward	+75K sh	$3.20	+$240K	375,000

Recent filings

Accepted (ET)
Sep 234
MERRIWEATHER ALFRED G0001209191-19-050455
SEC(opens sec.gov)
Apr 104
MERRIWEATHER ALFRED G0001209191-19-024239
SEC(opens sec.gov)
Mar 214
MERRIWEATHER ALFRED G0001209191-19-020792
SEC(opens sec.gov)
Sep 214
MERRIWEATHER ALFRED G0001209191-18-051991
SEC(opens sec.gov)
Mar 94
MERRIWEATHER ALFRED G0001209191-18-018672
SEC(opens sec.gov)
Jul 104
Adamas Pharmaceuticals Inc0001209191-17-044648
SEC(opens sec.gov)
May 194
MERRIWEATHER ALFRED G0001181431-11-031145
SEC(opens sec.gov)
May 124
MERRIWEATHER ALFRED G0001181431-11-029456
SEC(opens sec.gov)
May 64
MERRIWEATHER ALFRED G0001181431-11-027982
SEC(opens sec.gov)
Jan 44
MERRIWEATHER ALFRED G0001181431-11-001089
SEC(opens sec.gov)
Jan 224/A
Monogram Biosciences, Inc.0001209191-09-004464
SEC(opens sec.gov)
Jan 214
MERRIWEATHER ALFRED G0001209191-09-004250
SEC(opens sec.gov)
Feb 104
MERRIWEATHER ALFRED G0001211839-04-000001
SEC(opens sec.gov)

Companies

Address

C/O MONOGRAM BIOSCIENCES, INC. 345 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080